Drug Approvals

AbbVie's Decnupaz Secures FDA Approval for Rare Blood Cancer

FDA · blastic plasmacytoid dendritic cell neoplasm · 5 min

Eli Lilly's Retatrutide Success Amidst Regulatory Shifts: A Strategic Analysis

FDA · 9 min

Roche's Alecensa Secures Expanded Approval in Japan for ALK-Positive Lung Cancer

FDA · ALK Tumors · 9 min

Biogen Faces Italian Antitrust Probe: What It Means for the Multiple Sclerosis Market

FDA · multiple sclerosis · 10 min

Candel's Prostate Cancer Drug: Long-Term Data Insights Ahead of FDA Filing

FDA · prostate cancer · 8 min

Biogen's Alzheimer's Data and Leadership Shake-up: Implications for Pharma BD

FDA · Alzheimer's disease · 10 min

FDA Draft Guidance Slashes Biosimilar PK Study Costs, Accelerating Market Entry

FDA · 6 min

FDA Approves Atezolizumab for ctDNA MRD-Positive MIBC: A New Era for Adjuvant Therapy

FDA · muscle invasive bladder cancer · 7 min

FDA Leadership Vacuum: Navigating Uncertainty for Pharmaceutical Business Development

FDA · 9 min

FDA's New Stance on Drug Pricing: Impact on Approvals and Pharma Strategy

FDA · 7 min

Amgen and Zai Lab Leadership Shifts: Strategic Implications for Pharma BD and Investors

FDA · neurology · 8 min

Lilly and Gilead Drive Pharma M&A Surge: A Strategic Market Analysis

FDA · cancer · 7 min